Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

News Highlights

  • Final analysis inclusive of the 60-day safety update in the randomized placebo-controlled study demonstrated CERC-002 was statistically significant in reducing respiratory failure and mortality at Day 28 in patients hospitalized with COVID-19 associated pneumonia and mild to moderate acute respiratory distress syndrome (ARDS), the primary endpoint, (p=0.044)
  • Efficacy was highest in patients over the age of 60, the population most vulnerable to severe complications and death with COVID-19 infection
  • At both the 28-day and the 60-day final timepoints, an approximately 50% trend in mortality reduction (22.5% vs 10.8%) was observed
  • Results were observed on top of standard of care including high dose steroids (>90%) and remdesivir (>65%)
  • Cerecor has applied for FDA Breakthrough Therapy and Fast Track Designations, and plans to meet with FDA to discuss potential path to Emergency Use Authorization

ROCKVILLE, Md. and CHESTERBROOK, Pa., March 02, 2021 (News) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced final efficacy data including 60-day mortality from their recently completed US-based, multi-center (10 sites), Phase 2 trial (NCT04412057) of the human anti-LIGHT (TNFSF14) monoclonal antibody CERC-002. This analysis updates the preliminary topline data reported on January 5, 2021. All patients in this trial were hospitalized with COVID-19 associated pneumonia and mild-to-moderate acute respiratory distress syndrome (“ARDS”). A total of 83 patients were randomized 1:1 to receive standard of care at the sites plus either a single dose of 1,200 mg of CERC-002 or placebo subcutaneously. Due to the protocol allowing patients to receive high flow oxygen prior to randomization, 62 patients were included in the intention-to-treat (ITT) analysis of the primary endpoint.

The final analysis inclusive of the 60-day safety update demonstrated the trial met its primary efficacy endpoint (proportion of patients alive and free of respiratory failure over the 28-day study period) compared to placebo in COVID-19 patients with ARDS treated with a single dose of the anti-LIGHT monoclonal antibody CERC-002 (n=62, p=0.044). Efficacy was highest in a prespecified subpopulation of patients over the age of 60 (n=34, p=0.042), the population most vulnerable to severe complications and death with COVID-19 infection.

At both the 28-day and the 60-day final timepoints, an approximately 50% trend in mortality reduction (22.5% vs 10.8%) was observed.

CERC-002 showed statistically significant efficacy on top of corticosteroids and standard of care treatments in COVID-19 ARDS: over 90% of patients received concomitant systemic corticosteroids and over 65% received remdesivir. CERC-002 was well-tolerated. No drug-related serious adverse effects (SAEs) were reported in the trial, and there was no increase in infections in CERC-002 treated patients.

Cerecor has submitted applications to the U.S. Food and Drug Administration (FDA) for Breakthrough Therapy and Fast Track Designations. The Company plans to meet with FDA to discuss the potential path to Emergency Use Authorization (EUA) and approval.

“We would like to thank the patients who participated in this landmark study. These results not only validate our hypothesis that elevated LIGHT is a key driver of morbidity and mortality in COVID-19 ARDS1, but also provide strong initial evidence that LIGHT neutralization with CERC-002 in this setting may be able to save lives and can spare patients from the need for ventilatory support,” said H. Jeffrey Wilkins, MD, Chief Medical Officer of Cerecor. “These results are all the more encouraging given that this novel targeted therapy demonstrated efficacy and excellent tolerability despite being administered over and above standard of care including high dose systemic corticosteroids.”

“Despite progress with vaccinations, thousands of people in the US and around the world continue to die of COVID-19 related cytokine release syndrome and ARDS every day. There is an urgent need for new safe and effective therapies to treat these patients,” said Dr. David Perlin, Ph.D., Chief Scientific Officer and Senior Vice President of the Center for Discovery and Innovation at the Hackensack Meridian School of Medicine. “The need is all the greater given the increasing levels of COVID-19 mutation and resistance emerging in variants. Even with widespread vaccination such therapies will be required for many years to come.”

A presentation of these data updates can be found on the Investors section of the Cerecor website linked here.

CERC-002 (anti-LIGHT monoclonal antibody)

CERC-002 is a fully human anti-LIGHT or tumor necrosis factor superfamily member 14 (TNFSF14) monoclonal antibody licensed from Kyowa Kirin Co., Ltd. It is the only clinical stage anti-LIGHT therapy and has the potential to treat a number of LIGHT-associated immune diseases including cytokine storm-induced COVID-19 ARDS. It is currently in development for pediatric onset Crohn’s disease and cytokine storm induced COVID-19 ARDS. Cerecor has also developed a validated, high sensitivity serum/plasma free LIGHT assay in collaboration with Myriad RBM.

Role of LIGHT in Acute Inflammatory Response

LIGHT (homologous to Lymphotoxin, exhibits inducible expression and competes with HSV glycoprotein D for binding to herpesvirus entry mediator, a receptor expressed on T lymphocytes) is a cytokine with inflammatory actions encoded by the TNFSF14 gene. LIGHT plays an important role in regulating immune responses in the lung, gut and skin. It stimulates T Cell and B Cell response as well as induces the release of other cytokines such as IL-1, IL-6, IL-8, IL-10, TNF and GM-CSF. Therefore, LIGHT potentially plays a key role in immune responses to viral pneumonia and other diseases.

About Cerecor

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company’s rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn’s disease, and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)), and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.

For more information about Cerecor, please visit www.cerecor.com.

Forward-Looking Statements

This press release may include forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to significant risks and uncertainties that are subject to change based on various factors (many of which are beyond Cerecor’s control), which could cause actual results to differ from the forward-looking statements. Such statements may include, without limitation, statements with respect to Cerecor’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “might,” “will,” “could,” “would,” “should,” “continue,” “seeks,” “aims,” “predicts,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” or similar expressions (including their use in the negative), or by discussions of future matters such as: the development of product candidates or products; timing and success of trial results and regulatory review; potential attributes and benefits of product candidates; and other statements that are not historical. These statements are based upon the current beliefs and expectations of Cerecor’s management but are subject to significant risks and uncertainties, including: drug development costs, timing and other risks, including reliance on investigators and enrollment of patients in clinical trials, which might be slowed by the COVID-19 pandemic; regulatory risks; Cerecor’s cash position and the need for it to raise additional capital; general economic and market risks and uncertainties, including those caused by the COVID-19 pandemic; and those other risks detailed in Cerecor’s filings with the Securities and Exchange Commission. Actual results may differ from those set forth in the forward-looking statements. Except as required by applicable law, Cerecor expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Cerecor’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

For media and investor inquiries

Chris BrinzeyWestwicke, an ICR Companychris.brinzey@westwicke.com339-970-2843

or

James Harrell Investor RelationsChief Commercial OfficerCerecor Inc.jharrell@cerecor.com623.439.2220 office

1 Perlin DS, Zafir-Lavie I, Roadcap L, et al Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS. mSphere. 2020 Aug 12;5(4):e00699-20.

  • Check the latest Health news updates and information.
  • Please share this news Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS with your friends and family to support us your one share helps us a lot.
Disclaimer: If you need to edit or update this news from compsmag then kindly contact us Learn more

For Latest News Follow us on Google News


Latest Headlines
  • Show all
  • Trending News
  • Popular By week
Health highlights: April 9, 2021 – Consumer Health News

Health highlights: April 9, 2021 – Consumer Health News

Decrease Seen in U.S. Suicide Rate In addition to streamlining operations at Buckingham Palace, he became a prominent advocate for British industry and ...
JLL Weighing Sale of Property Management Business in China

JLL Weighing Sale of Property Management News in China

Subscribe to Crain’s for $3.25 a week The company generated $3.1 billion in revenue from providing real estate services in Asia Pacific, of which 32% came ...
Blockchain Association's Kristin Smith talks about Biden administration and cryptography

Blockchain Association’s Kristin Smith talks about Biden administration and cryptography

Has Congress warmed to digital-assets yet? Kristin Smith It’s still a challenge, particularly for Congress, because they’re spread so thin. There’s definitely ...
Black Hawk County health officials work to vaccinate adults against COVID-19, repress hesitation |  Political News

Black Hawk County health officials work to vaccinate adults against COVID-19, repress hesitation | Political News

Your browser does not support the iframe HTML tag. Try viewing this in a modern browser like Chrome, Safari, Firefox or Internet Explorer 9 or later. She ...
Resilience restaurant aid funds to help business owners and employees

Resilience restaurant aid funds to help business owners and employees

Source fox40.com Suggest a Correction Close Modal Applications will be open from April 11-18 and can be submitted here: www.restaurantscare.org/resilience ...
US Space and Rocket Center receives $ 250,000 donation and establishes donation campaign

US Space and Rocket Center receives $ 250,000 donation and establishes donation campaign

Close Modal More information about the foundation and how to donate can be found at rocketcenterfoundation.org. Suggest a Correction The Space and ...
Xbox fans are getting excited about this adventure game tunic

Xbox fans are getting excited about this adventure game tunic

Are you hoping to hear more about Tunic soon? Let us know in the comments below. Tunic was highlighted in an Xbox Wire post as one of the 30 games coming ...
78 new cases of COVID-19 and two new deaths, reports Yakima Health District |  Update

78 new cases of COVID-19 and two new deaths, reports Yakima Health District | Update

Vaccine update According to the state Department of Health’s most recent numbers, the county had 213.7 new cases per 100,000 from March 7-30 and 6.3 new ...
Americans near the poverty line face significant gap in health care coverage, can forgo essential health care

Americans near the poverty line face significant gap in health care coverage, can forgo essential health care

Roberts and his colleagues suggest expanding Medicaid coverage to include those making at least 150% of the federal poverty limit, offering coverage on a ...
Fortnite: What is restarting a friend and how to do it

Fortnite: What is restarting a friend and how to do it

The process of participating in Fortnite’s Reboot a Friend program is actually easier than some gamers would expect. To begin, all a player has to do is simply ...
Fox River closes funding for private placement with excess of subscriptions

Fox River closes funding for private placement with excess of subscriptions

For further information, please contact: Story continues Stephen D. CasePresident & Chief Executive OfficerTel: (416) 972-9222www.fox-river.ca ABOUT FOX ...
Mental health tips while watching Derek Chauvin’s trial

Mental health tips while watching Derek Chauvin’s trial

A local psychologist says a big difference in people being glued to their TVs for other trials, such as the O.J. Simpson trial in the 90s, is people can see ...
WI Joint Finance Committee hosts hearing session on proposed budget

WI Joint Finance Committee hosts hearing session on proposed budget

“All the non-fiscal policy items are really a non-starter,” said Mark Born of the JFC. “Massive policy changes in the state of Wisconsin should not be done in ...
Progressives are asking Biden to add more medical and housing assistance to his infrastructure account.

Progressives are asking Biden to add more medical and housing assistance to his infrastructure account.

The caucus is also calling for significant increases for affordable housing, including allocating $70 million to renovate crumbling public housing buildings. ...
Show next
RSS Best 10 Guide by Compsmag
  • Best Electric Kettle In India April 10, 2021
    Are you looking for the Best Electric Kettle In India? An electric kettle is the simplest and easiest of all-electric kitchen appliances in your home. The Best electric kettles in India are created with the latest technology and therefore offer simple and efficient operation.  An electric kettle adds a spark to your studio, your inn, […]
    Mohit
  • Best Electric Hand Blender In India April 10, 2021
    Are you looking for the Best Electric Hand Blender In India? A hand blender, also known as an immersion blender or dipping blender, is a handy and portable alternative to conventional blenders, food processors, coffee grinders, and blenders that gives you the freedom to be comfortable and fast. A hand blender is a sleek and […]
    Mohit
  • Best Espresso Coffee Machines In India April 10, 2021
    Are you looking for the Best Espresso Coffee Machines In India of 2021? Nothing in the world can beat the taste and aroma of filter coffee made from freshly ground coffee beans. We tried to recreate the same magic using concepts such as “instant coffee” and so on.  Your espresso machines do not look like […]
    Mohit
  • The Best High Altitude Drones April 10, 2021
    Why would you want to fly your consumer drone far from its controller? Well, there are some huge advantages with flying the Best High Altitude Drones further and further in First Person View or FPV. This allows drone pilots to see things and go to places they would not otherwise see or visit. That’s pretty […]
    Mayank Bhardwaj
  • The Best DSLR Cameras Under $500 April 10, 2021
    Today, $500 is a budget big enough to buy a super-spiffy camera, which would have been unheard of five or ten years ago. If you had asked me a few years ago to give you a good selection for the Best DSLR cameras under $500, I would’ve struggled to make a half-worthy list. But today, thanks […]
    Mayank Bhardwaj
  • Best Bluetooth Car Tool Kit of 2021 April 10, 2021
    Bluetooth Car Tool Kit- If you want to stream music from a wireless device or make hands-free phone calls in your car, a Bluetooth car kit is what you need. According to the Centers for Disease Control and Prevention, the distracted drivers can kill nine people and leave 1,060 others injured every day in the USA. The […]
    Mohit
  • Best Sites To Improve Typing Skills April 9, 2021
    Today we’re discussing you about how to improve the typing speed and skills. Today the world is a computer world, and today every work is based on a PC for which the basic and must need is good typing speed and skills. If you are good at typing, then you can easily find and do […]
    Compsmag Team
  • Arduino Books For Beginners April 9, 2021
    Check out the Best Arduino Books For Beginners in 2021. Arduino is a language designed for interacting with operating interactive objects and digital devices. The best thing about Arduino is that it’s available for almost everyone. You need to do some technical skills to get involved, but building on the top of Arduino has not […]
    Mohit
  • The Best Wireless Gaming Headsets April 9, 2021
    Four or five years ago, choosing the wired gaming headsets over the wireless gaming headsets was a matter of course for most people. The world has changed since then. Nowadays, a Bluetooth gaming headset is no longer just a convenient option for gamers. It is now a legitimate candidate who can offer high-quality and lag-free […]
    Mayank Bhardwaj
  • Best 3D Printers Under $500 April 9, 2021
    Are you looking for the Best 3D Printers Under $500? We are here to help you. The market is full of high-quality 3D printers that you can get without letting your wallet empty. Here we refer to the best 3D printers under $500 that are available on the market. All products listed here have been carefully […]
    Mayank Bhardwaj
RSS Popular Blog and Tutorial Tips
  • Fix ‘Repeat Let­ters or Dou­ble Spac­ing’ Issue on MacBook April 6, 2021
    This article is about Fix ‘Repeat Let­ters or Dou­ble Spac­ing’ Issue on MacBook. So read this free guide, Fix ‘Repeat Let­ters or Dou­ble Spac­ing’ Issue on MacBook step by step. If you have query related to same article you may contact us. Fix ‘Repeat Let­ters or Dou­ble Spac­ing’ Issue on MacBook – Guide You already […]
    Geek Techy
  • How to Set up Touch ID on MacBook April 6, 2021
    This article is about How to Set up Touch ID on MacBook. So read this free guide, How to Set up Touch ID on MacBook step by step. If you have query related to same article you may contact us. How to Set up Touch ID on MacBook – Guide If you have a Mac with Touch ID, […]
    Geek Techy
  • How to Enable/Dis­able Bat­tery Health Man­age­ment on MacBook April 6, 2021
    This article is about How to Enable/Dis­able Bat­tery Health Man­age­ment on MacBook. So read this free guide, How to Enable/Dis­able Bat­tery Health Man­age­ment on MacBook step by step. If you have query related to same article you may contact us. How to Enable/Dis­able Bat­tery Health Man­age­ment on MacBook – Guide Apple implemented a new Battery […]
    Geek Techy
  • Apple Mail vs Out­look for Mac: Comparison and Review April 6, 2021
    This article is about Apple Mail vs Out­look for Mac: Comparison and Review. So read this free guide, Apple Mail vs Out­look for Mac: Comparison and Review step by step. If you have query related to same article you may contact us. Apple Mail vs Out­look for Mac: Comparison and Review – Guide Apple and […]
    Geek Techy
  • How to Get Rid of Man­aged By Your Orga­ni­za­tion in Chrome Browser on Mac April 6, 2021
    This article is about How to Get Rid of Man­aged By Your Orga­ni­za­tion in Chrome Browser on Mac. So read this free guide, How to Get Rid of Man­aged By Your Orga­ni­za­tion in Chrome Browser on Mac step by step. If you have query related to same article you may contact us. How to Get Rid of […]
    Geek Techy
  • Fix­ ‘Google Dri­ve Not Sync­ing on Mac’ Issue April 6, 2021
    This article is about Fix­ ‘Google Dri­ve Not Sync­ing on Mac’ Issue. So read this free guide, Fix­ ‘Google Dri­ve Not Sync­ing on Mac’ Issue step by step. If you have query related to same article you may contact us. Fix­ ‘Google Dri­ve Not Sync­ing on Mac’ Issue – Guide The Google Backup & Sync app works great […]
    Geek Techy
  • Setting Up Microsoft Edge Chromi­um on Mac: Guide April 6, 2021
    This article is about Setting Up Microsoft Edge Chromi­um on Mac: Guide. So read this free guide, Setting Up Microsoft Edge Chromi­um on Mac: Guide step by step. If you have query related to same article you may contact us. Setting Up Microsoft Edge Chromi­um on Mac: Guide – Guide Microsoft is leaving its own […]
    Geek Techy
  • How to Use Sticky Notes on iOS, Android, and Mac April 6, 2021
    This article is about How to Use Sticky Notes on iOS, Android, and Mac. So read this free guide, How to Use Sticky Notes on iOS, Android, and Mac step by step. If you have query related to same article you may contact us. How to Use Sticky Notes on iOS, Android, and Mac – Guide Sticky Notes […]
    Geek Techy
  • How to Locate Saved Wi-Fi Pass­words on Mac April 6, 2021
    This article is about How to Locate Saved Wi-Fi Pass­words on Mac. So read this free guide, How to Locate Saved Wi-Fi Pass­words on Mac step by step. If you have query related to same article you may contact us. How to Locate Saved Wi-Fi Pass­words on Mac – Guide Maybe you just bought a new device – […]
    Geek Techy
  • Import Chrome Pass­words to Safari Browser on Mac: Guide April 6, 2021
    This article is about Import Chrome Pass­words to Safari Browser on Mac: Guide. So read this free guide, Import Chrome Pass­words to Safari Browser on Mac: Guide step by step. If you have query related to same article you may contact us. Import Chrome Pass­words to Safari Browser on Mac: Guide – Guide Are you planning to switch […]
    Geek Techy
Compsmag - Latest News from tech, business and health
Logo